About Us
Our Mission
Company Profile
Executive Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
ProTcell platform
Pipeline
News
Press releases
Smart Stories
Partnering
Contact
Press Releases
All
Smart Stories
All
Press Releases
All
Factsheets
Update on Smart Immune's situation
April 1, 2025
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing
December 3, 2024
Smart Immune to Present ReSet-02 Phase I Preliminary Data and the Determination of the Recommended Dose at ASH 2024
November 5, 2024
Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials
October 23, 2024
Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial
May 2, 2024
Smart Immune appoints key new members to its Board of Directors
February 16, 2024
Next
→
